The Miller Lab
Meet The Team
Publications
Presentations
Posts
Software
Funding
Donate
Upcoming and Past Presentations
Upcoming and Past Presentations
Presentations
Order By
Default
Title
Date - Oldest
Date - Newest
Author
Advanced Non-Melanoma Skin Cancer in Veterans: Incorporating Advances in Immune Checkpoint Inhibitors to Optimize Outcomes
At this live CME course developed and produced by Plexus Communication, Dr. Miller explores key clinical practice insights for patients with advanced Non-Melanoma Skin Cancer
May 30, 2025
David M. Miller
A Tailored Approach to Non-Melanoma Skin Cancers: Managing the High-Risk Patient With Systemic Immune-Activating Therapy
At the 2025 ACMS meeting Drs. Miller and Patel discuss pearls in managing the high-risk patient with systemic immune-activating therapy
May 16, 2025
David M. Miller, Vishal A. Patel
The Evolving Treatment Landscape of Non-Melanoma Skin Cancer: Implications for Dermatology
At the GW School of Medicine Dermatology Grand Rounds, Dr. Miller provides an overview of the evolving treatment landscape of CSCC and its implications for dermatologists
May 15, 2025
David M. Miller
Merkel Cell Carcinoma Current Concepts in Diagnosis and Management
At a GW Dermatology resident lecutre in Washington D.C., Dr. Miller provides an overview of the current concepts in diagnosis and management of Merkel Cell Carcinoma
May 15, 2025
David M. Miller
Merkel Cell Carcinoma Current Concepts in Diagnosis and Management
At the 17th Annual UNC Conference on Melanoma and Complex Skin Cancers: A Multidisciplinary Perspective, and part of the Millis-Copeland Endowed Melanoma Lecture, Dr. Miller provides pearls on the current concepts in diagnosis and management of Merkel Cell Carcinoma
May 2, 2025
David M. Miller
Peri-Operative Management of CSCC
At the 17th Annual UNC Conference on Melanoma and Complex Skin Cancers: A Multidisciplinary Perspective, and part of the Millis-Copeland Endowed Melanoma Lecture, Dr. Miller provides pearls on the current concepts in perioperative management of Cutaneous Squamous Cell Carcinoma
May 2, 2025
David M. Miller
Society of Cutaneous Oncology Journal Club
At this live Society of Cutaneous Oncology Journal Club, Dr. Miller leads a discussion on the recently published CheckMate-358
Apr 10, 2025
David M. Miller
Advanced Non-Melanoma Skin Cancer in Veterans: Incorporating Advances in Immune Checkpoint Inhibitors to Optimize Outcomes
At this live CME course developed and produced by Plexus Communication, Dr. Miller explores key clinical practice insights for patients with advanced Non-Melanoma Skin Cancer
Mar 19, 2025
David M. Miller
Peri-operative Management of High-Risk CSCC
At the 2025, American Academy of Dermatology Annual Meeting ‘What’s New in the Management of Advanced Skin Cancer’ session, Dr. Miller provides pearls on the peri-operative management of high-risk CSCC
Mar 9, 2025
David M. Miller
Narrowing Nonmelanoma Skin Cancer Gaps With Neoadjuvant Immunotherapy: Multidisciplinary Strategies for Success
At a AiCME program held at the 2025 American Academy of Dermatology Annual Meeting, Drs. Miller and Patel explore key clinical practice insights for patients with high-risk resectable NMSC
Mar 9, 2025
David M. Miller, Vishal Patel
Society of Cutaneous Oncology Journal Club
At this live Society of Cutaneous Oncology Journal Club, Dr. Miller leads a discussion on ctDNA in MCC
Mar 3, 2025
David M. Miller
Advanced Non-Melanoma Skin Cancer in Veterans: Incorporating Advances in Immune Checkpoint Inhibitors to Optimize Outcomes
This program will explore key clinical practice insights for patients with advanced Non-Melanoma Skin Cancer
Feb 3, 2025
David M. Miller
Controversies in Gene Expression Profiling
ODAC Dermatology, Aesthetic & Surgical Conference “General Session”
Jan 19, 2025
David M. Miller
Immunotherapy for CSCC - What Dermatologists Should Know
ODAC Dermatology, Aesthetic & Surgical Conference “General Session”
Jan 19, 2025
David M. Miller
Collaborative Approaches to Optimize Basal Cell Carcinoma Care Within the Community
Management Pearls for Advanced BCC
Jan 8, 2025
David M. Miller
The Evolving Treatment Landscape for CSCC
Reflections on the evolving treatment landscape for CSCC
Oct 24, 2024
David M. Miller
Advanced Non-Melanoma Skin Cancer in Veterans: Incorporating Advances in Immune Checkpoint Inhibitors to Optimize Outcomes
This program will explore key clinical practice insights for patients with advanced Non-Melanoma Skin Cancer
Oct 1, 2024
David M. Miller
Optimizing Melanoma Outcomes in Rural and Underserved Communities: Adapting to Evolving Treatment Paradigms
We summarize the clinical evidence for the efficacy and safety of new and emerging therapeutic options and treatment strategies for cutaneous melanoma
Sep 28, 2024
David M. Miller
Update in the Management of Advanced Cutaneous Squamous Cell Carcinoma
This live program will explore key clinical practice insights for patients with advanced CSCC
Sep 21, 2024
David M. Miller
Update in the Management of Non-Resectable Melanoma
This live program will explore key clinical practice insights for patients with non-resectable melanoma
Sep 21, 2024
David M. Miller
Shifting the Approach to Nonmelanoma Skin Cancer in Dermatology
This live program will explore key clinical practice insights for patients with advanced Non-Melanoma Skin Cancer
Sep 20, 2024
David M. Miller
Advanced Non-Melanoma Skin Cancer in Veterans: Incorporating Advances in Immune Checkpoint Inhibitors to Optimize Outcomes
This program will explore key clinical practice insights for patients with advanced Non-Melanoma Skin Cancer
Sep 19, 2024
David M. Miller
A Clinician’s Roadmap to Improving Outcomes in Advanced Basal Cell Carcinoma: Guiding Principles for the Use of Immunotherapies
This program will explore key clinical practice insights for patients with advanced basal cell carcinoma
Sep 4, 2024
David M. Miller, Todd Schlessinger
Incorporating Multidisciplinary Care and Immunotherapy to Achieve Optimal Outcomes in Patients With Nonmelanoma Skin Cancers
This HoloVision program will explore key clinical practice insights for patients with advanced or metastatic basal cell or cutaneous squamous cell carcinomas
Aug 9, 2024
David M. Miller
Should Ipilimumab Be the New “Standard” for Refractory MCC?
We discuss the role of Ipilimumab in anti-PD1 refractory MCC
May 3, 2024
David M. Miller
Updates in Merkel Cell Carcinoma
Pearls on the current concepts in diagnosis and management of MCC
Mar 10, 2024
David M. Miller
Peri-operative Management of CSCC
Pearls on peri-omanagement of high-risk resectable CSCC
Mar 9, 2024
David M. Miller
The Prognostic Value of the MCPyV Serum Antibody Test
We discuss results from a dual-institution observational study
Mar 8, 2024
David M. Miller
Reshaping the Treatment Landscape in the Department of Veteran Affairs: Immunotherapy in Nonmelanoma Skin Cancer
This live virtual program will explore key clinical practice insights for patients with advanced or metastatic basal cell or cutaneous squamous cell carcinomas
Jan 19, 2024
David M. Miller
Melanoma Update
ODAC Dermatology, Aesthetic & Surgical Conference “Medical & Surgical Dermatology Topics”
Jan 14, 2024
David M. Miller
Merkel Cell Carcinoma- Current Concepts in Diagnosis and Management
ODAC Dermatology, Aesthetic & Surgical Conference “Non-Melanoma Skin Cancer Update”
Jan 13, 2024
David M. Miller
Reshaping the Treatment Landscape in the Department of Veteran Affairs: Immunotherapy in Nonmelanoma Skin Cancer
This live virtual program will explore key clinical practice insights for patients with advanced or metastatic basal cell or cutaneous squamous cell carcinomas
Jan 5, 2024
David M. Miller
Reshaping the Treatment Landscape in the Department of Veteran Affairs: Immunotherapy in Nonmelanoma Skin Cancer
This live virtual program will explore key clinical practice insights for patients with advanced or metastatic basal cell or cutaneous squamous cell carcinomas
Jan 3, 2024
David M. Miller
Interdisciplinary Management of Advanced Cutaneous Malignancy
Management Pearls for the Peri-Operative Management of Melanoma
Nov 3, 2023
Putting the Patient First. The Value of Personalized Medicine for Nonmelanoma Skin Cancers
Management Pearls for Advanced NMSC
Oct 22, 2023
Management of Cutaneous Melanoma
Management of Cutaneous Melanoma
Oct 11, 2023
David M. Miller
Merkel Cell Carcinoma - Current Concepts in Diagnosis and Management
Current concepts in diagnosis and management of MCC
Sep 22, 2023
David M. Miller
Nicotinamide For Skin Cancer After Transplant
Discuss the evidende behind the use of nicotinamide for skin cancer prevention
Sep 14, 2023
David M. Miller
Prognostic Significance of Initial AMERK Serostatus
We discuss results from a dual-institution observational study
Aug 18, 2023
David M. Miller
Immunotherapeutic Strategies in Skin Cancer
Primer on Immunotherapeutic Strategies in Skin Cancer
Aug 2, 2023
David M. Miller
StoryboardR - An R Package and Shiny Application Designed to Visualize Real-World Data From Clinical Patient Registries
We present an overview of the StoryboardR package
Jun 8, 2023
The Emerging Standard of Care - Immunotherapy in Non-Melanoma Skin Cancer
This live program will explore key clinical practice insights for patients with advanced or metastatic basal cell or cutaneous squamous cell carcinomas
Jun 5, 2023
David M. Miller
Mission - Impossible to Possible Using Immunotherapy for the Treatment of Nonmelanoma Skin Cancers
Management Pearls for Advanced CSCC
Jun 4, 2023
Checkpoint Inhibition Combinations in Melanoma: Evaluating Current Therapies and the Role of Anti-LAG3 Antibodies
This live virtual TeleECHO program will explore key clinical practice insights for patients with advanced melanoma
May 25, 2023
David M. Miller
Checkpoint Inhibition Combinations in Melanoma: Evaluating Current Therapies and the Role of Anti-LAG3 Antibodies
This live virtual TeleECHO program will explore key clinical practice insights for patients with advanced melanoma
May 22, 2023
David M. Miller
Checkpoint Inhibition Combinations in Melanoma: Evaluating Current Therapies and the Role of Anti-LAG3 Antibodies
This live virtual TeleECHO program will explore key clinical practice insights for patients with advanced melanoma
May 10, 2023
David M. Miller
Complementary Therapeutic Approaches: Mohs Micrographic Surgery and Immunotherapy in Non-Melanoma Skin Cancer
This live hybrid program will explore key clinical practice insights for patients with advanced and high-risk resectable NMSC
May 6, 2023
David M. Miller, Sailesh Konda
Checkpoint Inhibition Combinations in Melanoma: Evaluating Current Therapies and the Role of Anti-LAG3 Antibodies
This live virtual TeleECHO program will explore key clinical practice insights for patients with advanced melanoma
May 1, 2023
David M. Miller
mGODS - Monoclonal Gammopathies Of Dermatological Significance
Pearls for working up monclonal gammopathies in setting of dermatological disease
Apr 21, 2023
David M. Miller
Checkpoint Inhibition Combinations in Melanoma: Evaluating Current Therapies and the Role of Anti-LAG3 Antibodies
This live virtual TeleECHO program will explore key clinical practice insights for patients with advanced melanoma
Apr 12, 2023
David M. Miller
Checkpoint Inhibition Combinations in Melanoma: Evaluating Current Therapies and the Role of Anti-LAG3 Antibodies
This live virtual TeleECHO program will explore key clinical practice insights for patients with advanced melanoma
Apr 10, 2023
David M. Miller
Checkpoint Inhibition Combinations in Melanoma: Evaluating Current Therapies and the Role of Anti-LAG3 Antibodies
This live virtual TeleECHO program will explore key clinical practice insights for patients with advanced melanoma
Apr 6, 2023
David M. Miller
Integrating the Latest Evidence on Management of Basal Cell Carcinoma
We discuss implementation of evidence-based strategies for reducing disparities in basal cell carcinoma (BCC) care in rural and underserved settings
Apr 1, 2023
David M. Miller
Integrating Novel Treatment Approaches for Cutaneous Squamous Cell Carcinoma
We summarize the clinical evidence for the efficacy and safety of new and emerging therapeutic options and treatment strategies for cutaneous squamous cell carcinoma
Apr 1, 2023
David M. Miller
ICARUS
We discuss a trial concept for high-risk CSCC
Mar 31, 2023
David M. Miller
Checkpoint Inhibition Combinations in Melanoma: Evaluating Current Therapies and the Role of Anti-LAG3 Antibodies
This live virtual TeleECHO program will explore key clinical practice insights for patients with advanced melanoma
Mar 30, 2023
David M. Miller
Exploring Neoadjuvant Immunotherapies for Surgically Resectable Cutaneous Squamous Cell Carcinoma
This live program will explore key clinical practice insights for patients with advanced cutaneous squamous cell carcinoma
Mar 19, 2023
David M. Miller, Vishal A. Patel
Updates in Merkel Cell Carcinoma
Pearls on the current concepts in diagnosis and management of MCC
Mar 18, 2023
David M. Miller
Management of High Risk Uncommon Cutaneous Neoplasms
Pearls on the current concepts in diagnosis and management of uncommon cutaneous neoplasms
Mar 17, 2023
David M. Miller
Management of Operable Advanced NMSC
Pearls on the current concepts in diagnosis and management of operable non-melanoma skin cancer
Mar 17, 2023
David M. Miller
How do we implement systemic therapy to reduce recurrence of high-risk melanomas: from neoadjuvant to adjuvant therapy?
Pearls on the current concepts in peri-operative management of high-risk melanoma
Mar 17, 2023
David M. Miller
Checkpoint Inhibition Combinations in Melanoma: Evaluating Current Therapies and the Role of Anti-LAG3 Antibodies
This live virtual TeleECHO program will explore key clinical practice insights for patients with advanced melanoma
Mar 13, 2023
David M. Miller
Checkpoint Inhibition Combinations in Melanoma: Evaluating Current Therapies and the Role of Anti-LAG3 Antibodies
This live virtual TeleECHO program will explore key clinical practice insights for patients with advanced melanoma
Mar 9, 2023
David M. Miller
Checkpoint Inhibition Combinations in Melanoma: Evaluating Current Therapies and the Role of Anti-LAG3 Antibodies
This live virtual TeleECHO program will explore key clinical practice insights for patients with advanced melanoma
Mar 2, 2023
David M. Miller
Checkpoint Inhibition Combinations in Melanoma: Evaluating Current Therapies and the Role of Anti-LAG3 Antibodies
This live virtual TeleECHO program will explore key clinical practice insights for patients with advanced melanoma
Feb 23, 2023
David M. Miller
Checkpoint Inhibition Combinations in Melanoma: Evaluating Current Therapies and the Role of Anti-LAG3 Antibodies
This live virtual TeleECHO program will explore key clinical practice insights for patients with advanced melanoma
Feb 15, 2023
David M. Miller
Optimizing the Management of Patients With Advanced Non-Melanoma Skin Cancers in Community-Based Dermatology, Oncology, and Dermato-Oncology Practices
This live virtual TeleECHO program will explore key clinical practice insights for patients with advanced or metastatic basal cell or cutaneous squamous cell carcinomas
Feb 15, 2023
David M. Miller
Checkpoint Inhibition Combinations in Melanoma: Evaluating Current Therapies and the Role of Anti-LAG3 Antibodies
This live virtual TeleECHO program will explore key clinical practice insights for patients with advanced melanoma
Feb 13, 2023
David M. Miller
Optimizing the Management of Patients With Advanced Non-Melanoma Skin Cancers in Community-Based Dermatology, Oncology, and Dermato-Oncology Practices
This live virtual TeleECHO program will explore key clinical practice insights for patients with advanced or metastatic basal cell or cutaneous squamous cell carcinomas
Feb 8, 2023
David M. Miller
Optimizing the Management of Patients With Advanced Non-Melanoma Skin Cancers in Community-Based Dermatology, Oncology, and Dermato-Oncology Practices
Med Learning Group TeleECHO. Event URL
Feb 6, 2023
David M. Miller
New Systemic Therapies for the Treatment of Advanced Non-Melanoma Skin Cancers: Which of Your Patients May Benefit?
We review new systemic therapies for the Treatment of Advanced NMSCs
Jan 23, 2023
David M. Miller, Vishal A. Patel
The Essential Roles of Dermatologists in Managing Patients with Advanced Basal Cell Carcinoma
This gamification-based activity highlights how to diagnose, treat, and/or manage patients with advanced basal cell carcinoma.
Nov 22, 2022
David M. Miller
Optimizing the Management of Patients With Advanced Non-Melanoma Skin Cancers in Community-Based Dermatology, Oncology, and Dermato-Oncology Practices
This live virtual TeleECHO program will explore key clinical practice insights for patients with advanced or metastatic basal cell or cutaneous squamous cell carcinomas
Nov 21, 2022
David M. Miller
Optimizing the Management of Patients With Advanced Non-Melanoma Skin Cancers in Community-Based Dermatology, Oncology, and Dermato-Oncology Practices
This live virtual TeleECHO program will explore key clinical practice insights for patients with advanced or metastatic basal cell or cutaneous squamous cell carcinomas
Nov 18, 2022
David M. Miller
Optimizing the Management of Patients With Advanced Non-Melanoma Skin Cancers in Community-Based Dermatology, Oncology, and Dermato-Oncology Practices
This live virtual TeleECHO program will explore key clinical practice insights for patients with advanced or metastatic basal cell or cutaneous squamous cell carcinomas
Nov 17, 2022
David M. Miller
Optimizing the Management of Patients With Advanced Non-Melanoma Skin Cancers in Community-Based Dermatology, Oncology, and Dermato-Oncology Practices
Med Learning Group TeleECHO. Event URL
Nov 9, 2022
David M. Miller
Cutaneous Malignancies: How Would You Manage This Patient?
Interactive session with a series of skin cancer experts discussing management of complex skin cancer patients.
Nov 4, 2022
David M. Miller, Douglas Grossman, Steven Wang, Vishal A. Patel
Prognostic Gene Expression Profiling for Cutaneous Squamous Cell Carcinoma: Does it Add to Staging
We discuss the current data regarding prognostic gene expression profiling in CSCC
Nov 4, 2022
David M. Miller
Cases in Basal Cell Carcinoma: Fostering Interdisciplinary Care
We discuss cases in the management of advanced BCC.
Nov 4, 2022
David M. Miller, Kavita Sarin, Vishal A. Patel
Optimizing the Management of Patients With Advanced Non-Melanoma Skin Cancers in Community-Based Dermatology, Oncology, and Dermato-Oncology Practices
Med Learning Group TeleECHO. Event URL
Oct 26, 2022
David M. Miller
Practical Management Pearls for Immunotherapy for the Treatment of Nonmelanoma Skin Cancer
We discuss perals from the recent SITC practice guidelines on NMSC
Oct 3, 2022
Isaac Brownell, David M. Miller, Sunandana Chandra, Emily S. Ruiz
Immunotherapeutic Strategies in Skin Cancer
Primer on Immunotherapeutic Strategies in Skin Cancer
Aug 17, 2022
David M. Miller
The Clinician Investigator - A Buttress Against Type III Error or a Contributor to the Crisis in Reproducibility?
In this two part series, we discuss elements of the crisis in reproducibility in clinical research.
Jul 11, 2022
David M. Miller
Dealing with Non-Responders to Systemic Therapy for Basal Cell Carcinoma
In this podcase, we discuss pearls on the management of advanced BCC
Jun 13, 2022
David M. Miller
mGODS - Monoclonal Gammopathies Of Dermatological Significance
Pearls for working up monclonal gammopathies in setting of dermatological disease
May 6, 2022
David M. Miller
Merkel Cell Carcinoma- Current Concepts in Diagnosis and Management
Pearls in the management of Merkel Cell Carcinoma
Apr 30, 2022
David M. Miller
Basal Cell Carcinoma: How to Effectively Manage Your Patients
Pearls in the management of Basal Cell Carcinoma
Apr 30, 2022
David M. Miller
Diagnostic Yield of Staging Brain MRI in Merkel Cell Carcinoma
Real world evaluation of initial brain MRI in MCC
Apr 26, 2022
David M. Miller
Real-world assessment of ipi-nivo in anti-PD-(L)-1 refractory Merkel Cell Carcinoma
Real world evaluation of ipilimumab/nivolumab in PD-1/PDL-1 refractory MCC
Apr 25, 2022
Sophia-Shalhout
Seeing Nonmelanoma Skin Cancers Through a New Lens - The Role and Place of Immunotherapy
Pearls on the current concepts in diagnosis and management of NMSC
Apr 22, 2022
Axel Hauschild, David M. Miller, Vishal Patel
Merkel Cell Carcinoma - Current Concepts in Diagnosis and Management
Pearls on the current concepts in diagnosis and management of MCC
Mar 28, 2022
David M. Miller
Real-world assessment of ipi-nivo in anti-PD-(L)-1 refractory Merkel Cell Carcinoma
Real world evaluation of ipilimumab/nivolumab in PD-1/PDL-1 refractory MCC
Mar 25, 2022
Sophia-Shalhout
Peer Insights on the Management of Patients With Cutaneous Squamous Cell Carcinoma
Management Pearls for Advanced CSCC
Mar 25, 2022
Kevin Emerick, David M. Miller
Peer Insights on the Management of Patients With Cutaneous Squamous Cell Carcinoma
Management Pearls for Advanced CSCC
Mar 18, 2022
Kevin Emerick, David M. Miller
Management of Advanced Cutaneous Melanoma
Pearls for the work up and management of cutaneous melanoma
Mar 10, 2022
David M. Miller
Non Melanoma Skin Cancer Immunotherapies and the Role of Dermatology Clinicians
Management Pearls for Advanced NMSC
Mar 1, 2022
Vishal Patel, Krista Rubin, David M. Miller
Immunotherapy in Advanced NMSC - Treatment Selection and Collaborative Care
Pearls for the Management of Advanced NMSC
Feb 14, 2022
Vishal Patel, Krista Rubin, David M. Miller
Generating an Anti-Tumor Response - Immune System Activation for the Treatment of Advanced/Metastatic BCC and cSCC
Pearls for the Management of Advanced NMSC
Jan 14, 2022
David M. Miller
Generating an Anti-Tumor Response - Immune System Activation for the Treatment of Advanced/Metastatic BCC and cSCC
Pearls for the Management of Advanced NMSC
Jan 7, 2022
David M. Miller
Generating an Anti-Tumor Response - Immune System Activation for the Treatment of Advanced/Metastatic BCC and cSCC
This live virtual Grand Rounds program will explore key clinical practice insights for patients with advanced or metastatic basal cell or cutaneous squamous cell carcinomas
Dec 14, 2021
David M. Miller
Clinical and Translational Research in Cutaneous Oncology
Pearls for a career in CT research in skin cancer
Dec 3, 2021
David M. Miller
Management of Cutaneous Melanoma
In this lecture to the Harvard Dermatology residents, we provide pearls for the management of cutaneous melanoma
Dec 3, 2021
David M. Miller
Accelerate Health
At the 2021 CEO Roundtable on Cancer Annual Conference we provide an update on the PDS MCC patient registry
Nov 17, 2021
David M. Miller, Kerry Reynolds, Bill Louv
Generating an Anti-Tumor Response - Immune System Activation for the Treatment of Advanced/Metastatic BCC and cSCC
Pearls for the Management of Advanced NMSC
Nov 11, 2021
David M. Miller
The MCC Patient Registry - From Promise to Prototype to Patient
For this MGH Dermatology Grand Rounds we present an overview of the PDS MCC patient registry
Nov 2, 2021
David M. Miller
Generating an Anti-Tumor Response - Immune System Activation for the Treatment of Advanced/Metastatic BCC and cSCC
Pearls for the Management of Advanced NMSC
Oct 8, 2021
David M. Miller
Squamous Cell Carcinoma - Current Concepts in Management
In this lecture for the Nurse Practioners on the Medical Oncology Inpatient Service, we reivew pearls on the current concepts in management of SCC
Oct 4, 2021
David M. Miller
GENETEX - A GENomics Report TEXt Mining R Package to Capture Real-World Clinico-genomic Data
We present an overview of the GENETEX package
Aug 26, 2021
David M. Miller, Sophia-Shalhout
Nonmelanoma Skin Cancers - Who Is in the Waiting Room
Pearls on the current concepts in diagnosis and management of NMSC
Aug 7, 2021
David M. Miller, Hari Nadiminti, Vishal Patel
Merkel Cell Carcinoma - Current Concepts in Diagnosis and Management
In this talk for the Summer AAD we review pearls on the current concepts in diagnosis and management of MCC.
Aug 7, 2021
David M. Miller
Diagnostic Yield of Staging Brain MRI in Merkel Cell Carcinoma
We discuss the utility of brain MRI for the initial staging of MCC
Jul 19, 2021
Farees Saqlain
Merkel Cell Carcinoma - Current Concepts in Diagnosis and Management
Pearls on the current concepts in diagnosis and management of MCC
Jun 11, 2021
David M. Miller
eLAB - a Large-Scale Laboratory Integration Informatics Pipeline for Clinical Research
May 17, 2021
Sophia-Shalhout
GENETEX - an NLP R Package for Text Mining Genomic Reports
May 7, 2021
David M. Miller
Immune Checkpoint Inhibitor for Cutaneous Squamous Cell Carcinoma
Pearls for the Management of Advanced CSCC
Apr 22, 2021
Kevin Emerick, Gina Jefferson, Miriam Lango, Matthew Witek, David M. Miller
An Innovative View of Advanced and Metastatic Basal Cell Carcinoma- Pathology, Epidemiology, and Treatment Option
Pearls for the Management of Advanced BCC
Mar 22, 2021
David M. Miller, Emily Ruiz
mGODS - Monoclonal Gammopathies Of Dermatological Significance
Pearls for working up monclonal gammopathies in setting of dermatological disease
Mar 18, 2021
David M. Miller
MCC Patient Registry - Lessons Learned, Future Directions
Mar 11, 2021
David M. Miller
MCC Patient Registry - Lessons Learned on Data Capture
Feb 26, 2021
David M. Miller
Work Up and Management of Cutaneous Melanoma
In this online lecture for the DC Resident Consortium, we provide pearls for the work up and management of cutaneous melanoma
Feb 25, 2021
David M. Miller
Project Data Sphere & MCC patient Registry- From Promise to Prototype to Patient
We provide updates and future directions of the PDS-GOBDA MCC Registry
Feb 23, 2021
David M. Miller
Developing Immunotherapy for Advanced Disease - Leveraging the Tumorigenesis of Basal Cell Skin Cancer – A Whiteboard View
Pearls for the Management of Advanced BCC
Jan 27, 2021
David M. Miller, Emily Ruiz
Project Data Sphere & MCC patient Registry- From Promise to Prototype to Patient
We provide updates and future directions of the PDS MCC Registry
Jan 22, 2021
David M. Miller
Squamous Cell Carcinoma - Work Up and Management
Pearls for the Work Up & Management of CSCC
Sep 9, 2020
David M. Miller
The Evolving Landscape of Regulatory Medicine in Cutaneous Oncology
Analysis of the changing regulatory environment in skin cancer
Sep 9, 2020
David M. Miller
Management of Cutaneous Melanoma
Pearls for the management of cutaneous melanoma
Aug 21, 2020
David M. Miller
The MCC Patient Registry - Updates and Future Directions
David Miller
Isaac Brownell
Ting Yu
Hazel Moran
Ravikumar Komandur
Bill Louv
Teilo Schaller
Johnathan Rine
Aug 7, 2020
David M. Miller
Salt, Water, Urine, EAV
Pearls for the Evaluation of Hyponatremia
Practical pearls to help evaluate hyponatremia
May 24, 2020
David M. Miller
Acid-Base Pearls Part 1
The Strong Ion Approach to Acid-Base Disorders
Pearls on how to approach
Acid-Base
issues commonly seen on inpatient medicine
May 23, 2020
David M. Miller
Pearls from the Cascade
Overview & Learning Objectives
May 22, 2020
David M. Miller
Merkel Cell Carcinoma - Current Concepts in Diagnosis and Management
Overview & Learning Objectives
Apr 16, 2020
David M. Miller
Squamous Cell Carcinoma - Epidemiology, Pathophysiology, Work Up and Management
Overview & Learning Objectives
Feb 28, 2020
David M. Miller
Heme-Derm - Principles at the Intersection of Blood and Skin
We review overlapping principles of Dermatology and Hematology
Feb 28, 2020
David M. Miller
Merkel Cell Carcinoma - Current Concepts in Diagnosis and Management
We review current concepts in diagnosis and management for MCC
Feb 8, 2020
David M. Miller
The MCC Patient Registry - From Promise to Prototype to Patient
Jan 31, 2020
David M. Miller
MCC Patient Registry - Updates and Future Directions
Jan 29, 2020
David M. Miller
Skin Toxicities of Anti-Neoplastic Medications
Jan 27, 2020
David M. Miller
Melanoma - Pathogenesis, Clinical Features, Work Up & Management
We review key pearls in melanoma pathogenesis and management
Jan 23, 2020
David M. Miller
Therapeutic Updates in Melanoma - IO for Earlier Stage Disease
This site represents our opinions only. See our full Disclaimer and Terms of Use Agreement
Jan 18, 2020
David M. Miller
Merkel Cell Carcinoma- Current Concepts in Diagnosis and Management
This site represents our opinions only. See our full Disclaimer and Terms of Use Agreement
Jan 17, 2020
David M. Miller
The Evolving Landscape of Regulatory Medicine in Cutaneous Oncology
Dec 13, 2019
David M. Miller
Melanoma - Pathogenesis, Clinical Features, Diagnosis and Management
Dec 13, 2019
David M. Miller
Targeting the Hippo-YAP Pathway As a novel Therapeutic Approach in Cancer
Dec 12, 2019
Sophia-Shalhout
A Case of Bimodality Therapy for Merkel Cell Carcinoma
Dec 3, 2019
Farees Saqlain
Clinical Investigation in cSCC - Updates from ASCO and ESMO
Nov 19, 2019
David M. Miller
Project Data Sphere and Ongoing Multi-Institutional Database Efforts
We present on the PDS MCC patient registry at the First International Symposium on Merkel Cell Carcinoma
Oct 21, 2019
David M. Miller
2019 ASCO IO Abstracts Review
Oct 7, 2019
David M. Miller
Work Up and Management of Non-Melanoma Skin Cancer
Aug 23, 2019
David M. Miller
Diagnosis and Initial Management of Melanoma
Aug 23, 2019
David M. Miller
MCC Patient Registry
Aug 20, 2019
Melanoma - Work Up and Management
Aug 2, 2019
David M. Miller
Melanoma - Epidemiology and Pathogenesis
Aug 1, 2019
David M. Miller
Merkel Cell Carcinoma Tumor Registry
Jun 18, 2019
David M. Miller
Approach to the Skin Biopsy
Jun 10, 2019
David M. Miller
Project Data Sphere & MCC patient Registry- From Promise to Prototype to Patient
Jun 2, 2019
Clinical and Translational Research in Cutaneous Oncology
May 20, 2019
David M. Miller
Cutaneous Oncology Board Preparation
May 20, 2019
David M. Miller
Regulatory Medicine in Cutaneous Oncology
May 7, 2019
David M. Miller
Merkel Cell Carcinoma
In this lecture for the GWU School of Medicine Dermatology residents we provide a overview of the diagnosis and managment of Merkel Cell Carcinoma
Apr 18, 2019
David M. Miller
Regulatory Medicine in Cutaneous Oncology
Apr 2, 2019
David M. Miller
Neoadjuvant PD-1 Blockade in Resectable Melanoma
Mar 25, 2019
David M. Miller
Project Data Sphere & the MCC Patient Registry - From Promise to Prototype to Patient
We present the concept of the PDS MCC patient registry at the annual Merkel Cell Carcinoma Interest Group Meeting
Mar 1, 2019
David M. Miller
Sezary Syndrome Part 2 - Diagnosis and Management
Feb 22, 2019
David M. Miller
Sezary Syndrome Part 1 - Pathogenesis and Clinical Features
Feb 15, 2019
David M. Miller
mGODS - Monoclonal Gammopathies Of Dermatological Significance
First described↩︎
Feb 8, 2019
David M. Miller
mGODS - Monoclonal Gammopathies of Dermatological Signficance
(https://www.themillerlab.io/talk/harvard_derm_resident_mgods-01-31-17/)↩︎
Jan 17, 2019
David M. Miller
Sezary Syndrome
Jan 17, 2019
David M. Miller
Reducing M&M in M&M - Strategies to improve Morbidity and Mortality in Melanoma and Merkel cell carcinoma
Dec 19, 2018
David M. Miller
FDA Action in Cutaneous Oncology
Overview of regulatory medicine in skin cancer
Nov 9, 2018
David M. Miller
Sezary Syndrome
Nov 9, 2018
David M. Miller
PDS MCC Tumor Registry
Oct 22, 2018
David M. Miller
FDA Action in Cutaneous Oncology
Oct 22, 2018
PAMPs, DAMPs and Dermatology
Aug 24, 2018
David M. Miller
TCRs, Tsubs and dHSRs - T-cell Immunity for the Dermatologist
Aug 24, 2018
David M. Miller
Introduction to Melanoma
Jul 31, 2018
David M. Miller
Merkel Cell Carcinoma - Updates in Diagnosis and Management
Jun 14, 2018
David M. Miller
Merkel Cell Carcinoma
May 18, 2018
David M. Miller
Introduction to Melanoma
May 18, 2018
The Biology of Cutaneous Oncology
May 18, 2018
David M. Miller
mGODS - Monoclonal Gammopathies of Dermatological Signficance
First described↩︎
May 18, 2018
David M. Miller
PAMPs DAMPs and Dermatology - Innate Immunity for the Dermatologist
May 8, 2018
David M. Miller
mGODS - Monoclonal Gammopathies Of Dermatological Significance
First described↩︎
Dec 19, 2017
David M. Miller
No Claims No Gains - Why You Need to Know the Business Side of Medicine
Dec 14, 2017
David M. Miller, Xin Gao
Common Primary Care Dermatoses
Dec 8, 2017
David M. Miller
Sezary Syndrome
Nov 21, 2017
David M. Miller
Nivolumab as Adjuvant Therapy for Melanoma
Oct 31, 2017
David M. Miller
Common Primary Care Dermatoses
Oct 6, 2017
David M. Miller
Common Primary Care Dermatoses
Sep 22, 2017
David M. Miller
Introduction to Melanoma
Aug 15, 2017
David M. Miller
Sezary Syndrome
May 30, 2017
David M. Miller
Sezary Syndrome
May 24, 2017
David M. Miller
Avelumab for Patients with Merkel Cell Carcinoma
May 2, 2017
David M. Miller
mGODS - Monoclonal Gammopathies Of Dermatological Significance
In this lecture we review the most common dermatoses that result from monoclonal gammopathies. The lecture also introduces the term
mGODS: Monoclonal Gammopathies of…
Jan 31, 2017
David M. Miller
Scratching the Surface of Acute Graft vs. Host Disease
Jun 10, 2016
David M. Miller
Approach to Purpura
Mar 25, 2016
David M. Miller
The Red Leg
Jan 29, 2016
David M. Miller
Mycosis Fungoides - Clinical Features, Diagnosis & Management
Jan 15, 2016
David M. Miller
Merkel Cell Carcinoma
Dec 3, 2015
David M. Miller
Cellulitis and Its Mimics
Nov 6, 2015
David M. Miller
Vesiculobullous Eruptions
Oct 9, 2015
David M. Miller
Common Primary Care Dermatoses
Jul 24, 2015
David M. Miller
A Case of Early-Onset Dementia
Jun 17, 2015
David M. Miller
A Patient with Fever and Rash
Jun 1, 2015
David M. Miller
A Painful Rash
Apr 15, 2015
David M. Miller
Melanoma
Mar 27, 2015
David M. Miller
Biology of Keratinocytes
Jan 28, 2015
David M. Miller
Emerging Therapies in Melanoma
Apr 16, 2014
David M. Miller
Environmental and Sports-Related Skin Diseases
Mar 5, 2014
David M. Miller
Overstimulated
Feb 19, 2014
David M. Miller
Immunology Review - T-Cell Immunity
Jan 5, 2014
David M. Miller
Progression After Failure
May 22, 2013
David M. Miller
Deep Impact
May 22, 2013
David M. Miller
Melanoma
Apr 26, 2013
David M. Miller
Environmental and Sports-Related Skin Diseases
Mar 20, 2013
David M. Miller
B-Cell Immunology for the Dermatologist
Aug 22, 2012
David M. Miller
T-Cell Immunology for the Dermatologist
Aug 15, 2012
David M. Miller
Biology of Keratinocytes
Aug 10, 2012
David M. Miller
Severe Scalp SCCs In a Heart Transplant Recipient
May 16, 2012
David M. Miller
Cutaneous B-Cell Lymphoma
Apr 25, 2012
David M. Miller
Melanoma
Apr 13, 2012
David M. Miller
Painful Papules
Jan 25, 2012
David M. Miller
No matching items
↑ Top